Host an event in support of Brain Tumour Foundation of Canada - Do it Your Way
Gliomas are the most common type of brain tumour in children, adolescents and young adults. An IDH mutation is a genetic change that can lead to glioma formation. IDH-mutant glioma is typically found in young adults, with these tumours universally progressing over time.
Glioblastoma (GBM) is a devastating brain tumour with limited treatment options. This project explores the role of the glymphatic system, the brain's waste removal and immune cell transport network, in GBM progression.
Although primary brain tumours vary widely in prognosis, people living with any brain tumour are at increased risk of cognitive deficits. These cognitive deficits can affect their ability to manage daily tasks, maintain social relationships, and continue to work or remain in school.
Meningioma is the most common primary brain tumour in adults. Although a large percentage are classified as benign, the more aggressive types of meningioma impose a significant morbidity and mortality burden on patients.
The current treatments for brain cancer do not work well and cause a lot of side-effects. This highlights the need to develop better treatments. There are several types of brain tumors. They differ in their age of onset, aggressiveness, and localization within the brain.
Attending school not only allows students to learn but the opportunity to develop interests, connect with peers, and form lifelong bonds. With your generous support we will explore pediatric brain tumour survivors' and their families' experience re-entering the education system after a cancer diagnosis.
Through their remarkable generosity, the Brain Tumour Foundation of Canada has enabled our interdisciplinary research group to develop artificial intelligence technologies to help discover new therapies against recurrent glioblastoma.
We hope this research will lead to the initiation of new clinical trials to optimize and expand the subset of patients with brain metastases who will derive the greatest clinical benefit from this therapy.
This research project, which has been 10 years in the making, is progressing very well, and will continue to do so thanks to this generous grant. Rest assured that we will continue to work tirelessly to improve the care of brain tumour patients.
I am thrilled and grateful to receive The Brain Tumour Foundation of Canada Mackenzie Rigg Brain Tumour Research Grant. These funds will launch an ambitious project in a completely new area of glioblastoma research, studying how age-related changes in the blood system fuel tumour growth.
In reading Allison's story, we see reflected many of our own patients and our own experiences as parents, daughters, partners, surgeons and researchers. This is a horrible cancer that robs families of time and memories.
I am grateful to the Brain Tumour Foundation of Canada and DUNN with Cancer for funding our Elevation Research Grant. This award provides vital resources to help our team advance research on novel biomarkers for high-grade gliomas.
There are so many ways you can help make a difference in the lives of patients and families today.
Reach out for support, education and information and to learn about research.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
This website uses the following additional cookies:
(List the cookies that you are using on the website here.)
